You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
4 November 2026 - Swedish precision oncology company CHOSA Oncology AB (Spotlight Stock Market: CHOSA) said on Wednesday it has signed an agreement with a CLIA-certified laboratory to develop and validate Platin-DRP as a laboratory-developed test for...
BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma
4 November 2026 - Oncology company BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160) (SSE: 688235) reported on Wednesday that it has received US Food and Drug Administration (FDA) Priority Review for its application to use BRUKINSA (zanubrutinib) with ...
4 November 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Wednesday that it has entered into an amended agreement with Arena Pharmaceuticals, a subsidiary of Pfizer Inc (NYSE:PFE), to eliminate all royalty obl...
4 November 2026 - Biotechnology company Pentixapharm Holding AG (Frankfurt Prime Standard: PTP) on Wednesday reported further progress towards its pivotal Phase 3 PANDA study, with US ethics approval secured and no concerns raised by the US Food and ...
4 November 2026 - ABIONYX Pharma (Euronext Paris:ABNX), a biopharma company focused on breakthrough biotherapies to address life-threatening conditions with no effective treatments, announced on Wednesday that it has signed a strategic partnership wi...
4 November 2026 - Chinese biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) announced on Tuesday that it has entered into a clinical collaboration agreement with US-based Kimia Therapeutics Inc, a biopharmaceutical company developing innov...
3 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that it has initiated ENHANCE-3, a Phase 3 clinical trial evaluating Ohtuvayre (ensifentrine) for preventing chron...